X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1303) 1303
Publication (200) 200
Patent (24) 24
Book Chapter (14) 14
Conference Proceeding (11) 11
Book Review (7) 7
Book / eBook (6) 6
Web Resource (4) 4
Magazine Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (833) 833
female (748) 748
oncology (665) 665
middle aged (488) 488
breast cancer (469) 469
breast neoplasms - drug therapy (459) 459
breast neoplasms - pathology (428) 428
adult (416) 416
aged (404) 404
index medicus (353) 353
antineoplastic combined chemotherapy protocols - therapeutic use (225) 225
prognosis (216) 216
chemotherapy (213) 213
cancer (173) 173
breast neoplasms - mortality (163) 163
treatment outcome (160) 160
survival (154) 154
neoplasm staging (152) 152
disease-free survival (148) 148
therapy (138) 138
breast neoplasms - genetics (135) 135
article (129) 129
aged, 80 and over (125) 125
retrospective studies (125) 125
breast neoplasms - therapy (123) 123
care and treatment (122) 122
research (120) 120
breast neoplasms - metabolism (119) 119
neoplasm metastasis (116) 116
chemotherapy, adjuvant (115) 115
breast neoplasms - surgery (107) 107
carcinoma (106) 106
antineoplastic agents - therapeutic use (97) 97
metastasis (97) 97
doxorubicin - administration & dosage (93) 93
trastuzumab (91) 91
combined modality therapy (89) 89
women (89) 89
risk factors (87) 87
medicine & public health (86) 86
neoadjuvant therapy (86) 86
cyclophosphamide - administration & dosage (83) 83
doxorubicin (80) 80
survival analysis (80) 80
fluorouracil - administration & dosage (77) 77
survival rate (77) 77
adjuvant chemotherapy (74) 74
time factors (72) 72
follow-up studies (71) 71
lymphatic metastasis (69) 69
antineoplastic combined chemotherapy protocols - adverse effects (66) 66
paclitaxel (65) 65
preoperative chemotherapy (64) 64
surgery (64) 64
proportional hazards models (62) 62
drug administration schedule (61) 61
receptor, erbb-2 - metabolism (61) 61
health aspects (60) 60
male (60) 60
patient outcomes (59) 59
animals (58) 58
cyclophosphamide (57) 57
expression (57) 57
neoadjuvant chemotherapy (57) 57
abridged index medicus (56) 56
risk (56) 56
tamoxifen (55) 55
trial (55) 55
tumors (55) 55
diagnosis (54) 54
kaplan-meier estimate (54) 54
drug therapy (53) 53
mastectomy (53) 53
recurrence (53) 53
cancer patients (52) 52
prospective studies (52) 52
antineoplastic agents - administration & dosage (51) 51
radiotherapy (51) 51
postmenopausal women (48) 48
bone neoplasms - secondary (47) 47
genetic aspects (47) 47
mice (47) 47
clinical trials as topic (46) 46
paclitaxel - administration & dosage (46) 46
breast-cancer (45) 45
multivariate analysis (45) 45
receptors, estrogen - analysis (45) 45
predictive value of tests (43) 43
analysis (42) 42
cell line, tumor (42) 42
docetaxel (42) 42
metastatic breast cancer (42) 42
receptors, estrogen - metabolism (42) 42
surgical adjuvant breast (42) 42
breast neoplasms - diagnosis (41) 41
antibodies, monoclonal, humanized (40) 40
randomized controlled trials as topic (40) 40
clinical trials (39) 39
gene expression (39) 39
mutation (39) 39
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Circulation Desk (1) 1
Scarborough Hospital - General (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


New England Journal of Medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 3, p. 289
Journal Article
BREAST CANCER RESEARCH, ISSN 1465-542X, 10/2018, Volume 20, Issue 1, pp. 123 - 11
Endocrine therapy is recommended for patients with hormone receptor-positive (HR+) advanced and metastatic breast cancer without visceral crisis (symptomatic... 
PALOMA-1/TRIO-18 | METASTASIS | Ribociclib | Endocrine therapy | 6 inhibitor | COMBINATION | MONALEESA-2 | PALBOCICLIB | WOMEN | THERAPY | ONCOLOGY | CDK4 | LETROZOLE | BONE | Hormone receptor-positive | HR+/HER2(-) breast cancer | Hormone receptors | Care and treatment | Cancer patients | Breast cancer | Drug therapy | Health aspects | Statistics | HER2− breast cancer | HR | Review | HR+/HER2− breast cancer | CDK4/6 inhibitor
Journal Article
2004, 2nd ed., ISBN 9781550092622, 880
Book
Cancer, ISSN 0008-543X, 07/2004, Volume 101, Issue 1, pp. 51 - 57
Journal Article
Oncologist, ISSN 1083-7159, 01/2015, Volume 20, pp. S1 - S1
The major purpose of this presentation is to describe the development of several generations of prognostic models in primary breast cancer and discuss the... 
Journal Article
The Oncologist, ISSN 1083-7159, 02/2019, Volume 24, Issue 2, pp. 178 - 184
Background Zoledronic acid (ZA), a potent bisphosphonate used for treatment of bone metastasis, has high bone affinity. This post hoc analysis evaluated the... 
Zoledronic acid | OPTIMIZE‐2 | Pharmacokinetics | Bone saturation | Long‐term dosing | OPTIMIZE-2 | Long-term dosing | EFFICACY | MECHANISM | SAFETY | RISK | PHARMACODYNAMICS | SYNTHASE | BISPHOSPHONATES | INHIBITION | ONCOLOGY | METASTATIC BREAST-CANCER
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 09/2019, p. clincanres.0463.2019
Adjuvant therapy for small, node-negative HER2-positive breast cancer (HER2+ BC) is controversial. We aimed to identify the subgroup that would benefit most... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 19, pp. 2101 - 2102
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2005, Volume 353, Issue 16, pp. 1734 - 1736
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3366 - 3379
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 4736 - 4736
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 1072 - 1072
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.